Quantcast

Osteopenia Global Clinical Trials Review, H2, 2013

November 27, 2013

Reportbuyer.com just published a new market research report: Osteopenia Global Clinical Trials Review, H2, 2013.

London (PRWEB) November 27, 2013

Osteopenia Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H2, 2013" provides data on the Osteopenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteopenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Osteopenia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Osteopenia 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by G7 Nations 17

Clinical Trials in G7 Nations by Trial Status 18

Clinical Trials by E7 Nations 19

Clinical Trials in E7 Nations by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Unaccomplished Trials of Osteopenia 24

Subjects Recruited Over a Period of Time 26

Prominent Sponsors 27

Top Companies Participating in Osteopenia Therapeutics Clinical Trials 29

Prominent Drug Comparison 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Amgen Inc. 32

Clinical Trial Overview of Amgen Inc. 32

Novartis AG 33

Clinical Trial Overview of Novartis AG 33

F. Hoffmann-La Roche Ltd. 34

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34

Nestle SA 35

Clinical Trial Overview of Nestle SA 35

Warner Chilcott Plc 36

Clinical Trial Overview of Warner Chilcott Plc 36

Integrative Health Technologies, Inc. 37

Clinical Trial Overview of Integrative Health Technologies, Inc. 37

Solvay Pharma Inc. 38

Clinical Trial Overview of Solvay Pharma Inc. 38

Duramed Research Inc. 39

Clinical Trial Overview of Duramed Research Inc. 39

Eidgenossische Technische Hochschule Zurich 40

Clinical Trial Overview of Eidgenossische Technische Hochschule Zurich 40

POM Wonderful, LLC. 41

Clinical Trial Overview of POM Wonderful, LLC. 41

Sanos Bioscience A/S 42

Clinical Trial Overview of Sanos Bioscience A/S 42

BioActor 43

Clinical Trial Overview of BioActor 43

Deltanoid Pharmaceuticals Inc. 44

Clinical Trial Overview of Deltanoid Pharmaceuticals Inc. 44

Emisphere Technologies, Inc. 45

Clinical Trial Overview of Emisphere Technologies, Inc. 45

Bayer AG 46

Clinical Trial Overview of Bayer AG 46

Azelon Pharmaceuticals Inc. 47

Clinical Trial Overview of Azelon Pharmaceuticals Inc. 47

Pfizer Inc. 48

Clinical Trial Overview of Pfizer Inc. 48

Marina Biotech, Inc. 49

Clinical Trial Overview of Marina Biotech, Inc. 49

GlaxoSmithKline plc 50

Clinical Trial Overview of GlaxoSmithKline plc 50

Sanofi 51

Clinical Trial Overview of Sanofi 51

Clinical Trial Overview of Top Institutes / Government 52

Massachusetts General Hospital 52

Clinical Trial Overview of Massachusetts General Hospital 52

National Institute of Arthritis and Musculoskeletal and Skin Diseases 53

Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 53

University of Wisconsin Madison 54

Clinical Trial Overview of University of Wisconsin Madison 54

King's College London 55

Clinical Trial Overview of King's College London 55

University of Messina 56

Clinical Trial Overview of University of Messina 56

Duquesne University 57

Clinical Trial Overview of Duquesne University 57

University of California, San Francisco 58

Clinical Trial Overview of University of California, San Francisco 58

Emory University 59

Clinical Trial Overview of Emory University 59

Hospices Civils de Lyon 60

Clinical Trial Overview of Hospices Civils de Lyon 60

National Taiwan University Hospital 61

Clinical Trial Overview of National Taiwan University Hospital 61

University of Sao Paulo 62

Clinical Trial Overview of University of Sao Paulo 62

Aarhus University 63

Clinical Trial Overview of Aarhus University 63

The National Institute of Allergy and Infectious Diseases 64

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 64

Mayo Clinic 65

Clinical Trial Overview of Mayo Clinic 65

University of Missouri 66

Clinical Trial Overview of University of Missouri 66

Medical University of Vienna 67

Clinical Trial Overview of Medical University of Vienna 67

U.S. Department of Veterans Affairs 68

Clinical Trial Overview of U.S. Department of Veterans Affairs 68

Queen's University 69

Clinical Trial Overview of Queen's University 69

University of Pennsylvania 70

Clinical Trial Overview of University of Pennsylvania 70

National Center for Research Resources 71

Clinical Trial Overview of National Center for Research Resources 71

Five Key Clinical Profiles 72

Appendix 164

Abbreviations 164

Definitions 164

Research Methodology 165

Secondary Research 165

About GlobalData 166

Contact Us 166

Disclaimer 166

Source 167

List of Tables

Osteopenia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8

Osteopenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Osteopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11

Osteopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12

Osteopenia Therapeutics Clinical Trials, North America, Top Countries, 2013* 13

Osteopenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14

Osteopenia Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15

Osteopenia Therapeutics Clinical Trials, BRIC Countries, 2013* 16

Osteopenia Therapeutics Clinical Trials, G7 Countries, 2013* 17

Osteopenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Osteopenia Therapeutics Clinical Trials, E7 Countries, 2013* 19

Osteopenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Osteopenia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21

Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22

Osteopenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Osteopenia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24

Osteopenia Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25

Osteopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26

Osteopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28

Osteopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30

Osteopenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 32

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 33

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 34

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle SA, 2013* 35

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Warner Chilcott Plc, 2013* 36

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Integrative Health Technologies, Inc., 2013* 37

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Solvay Pharma Inc., 2013* 38

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duramed Research Inc., 2013* 39

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eidgenossische Technische Hochschule Zurich, 2013* 40

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by POM Wonderful, LLC., 2013* 41

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanos Bioscience A/S, 2013* 42

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioActor, 2013* 43

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Deltanoid Pharmaceuticals Inc., 2013* 44

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emisphere Technologies, Inc., 2013* 45

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 46

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Azelon Pharmaceuticals Inc., 2013* 47

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 48

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Marina Biotech, Inc., 2013* 49

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 50

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 51

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 52

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2013* 53

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 54

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College London, 2013* 55

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Messina, 2013* 56

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duquesne University, 2013* 57

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 58

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 59

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2013* 60

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 61

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2013* 62

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2013* 63

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 64

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 65

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2013* 66

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 67

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 68

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2013* 69

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 70

Osteopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 71

List of Figures

Osteopenia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8

Osteopenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Osteopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11

Osteopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12

Osteopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13

Osteopenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14

Osteopenia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15

Osteopenia Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16

Osteopenia Therapeutics Clinical Trials, G7 Countries (%), 2013* 17

Osteopenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Osteopenia Therapeutics Clinical Trials, E7 Countries (%), 2013* 19

Osteopenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Osteopenia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21

Osteopenia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22

Osteopenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Osteopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26

Osteopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27

Osteopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29

Osteopenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31

GlobalData Methodology 165

Read the full report:

Osteopenia Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/osteopenia_global_clinical_trials_review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/11/prweb11375685.htm


Source: prweb



comments powered by Disqus